Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCIKarlstad Hosp, Dept Cardiol, Karlstad, Sweden..
Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark..
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm, Uppsala kliniska forskningscentrum (UCR).
Karlstad Hosp, Dept Cardiol, Karlstad, Sweden..
Sahlgrenska Univ, Dept Cardiol, Gothenburg, Sweden..
Örebro Univ, Fac Hlth, Dept Cardiol, Örebro, Sweden..
St Goran Hosp, Dept Cardiol, Stockholm, Sweden..
Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark..
Lund Univ, Skane Univ Hosp, Dept Cardiol, Clin Sci, Lund, Sweden..
Linköping Univ, Dept Cardiol, Linköping, Sweden.;Linköping Univ, Dept Med & Hlth Sci, Linköping, Sweden..
Vastmanland Hosp Vasters, Dept Internal Med, Västerås, Sweden..
Lund Univ, Skane Univ Hosp, Dept Cardiol, Clin Sci, Lund, Sweden..
Kalmar Cty Hosp, Dept Cardiol, Kalmar, Sweden.;Linnaeus Univ, Fac Hlth & Life Sci, Kalmar, Sweden..
Linköping Univ, Dept Cardiol, Linköping, Sweden.;Linköping Univ, Dept Med & Hlth Sci, Linköping, Sweden..
Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden.;Capio St Gorans Sjukhus, Unit Cardiol, Stockholm, Sweden.;Sundsvall Hosp, Dept Med, Sundsvall, Sweden..
Linköping Univ, Dept Cardiol, Linköping, Sweden.;Linköping Univ, Dept Med & Hlth Sci, Linköping, Sweden..
Lund Univ, Skane Univ Hosp, Dept Cardiol, Clin Sci, Lund, Sweden..
Örebro Univ, Fac Hlth, Dept Cardiol, Örebro, Sweden..
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm, Uppsala kliniska forskningscentrum (UCR). (kardiologi)
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för medicinska vetenskaper. Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm, Uppsala kliniska forskningscentrum (UCR).
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för medicinska vetenskaper. (UCR)
Visa övriga samt affilieringar
2017 (Engelska)Ingår i: New England Journal of Medicine, ISSN 0028-4793, E-ISSN 1533-4406, Vol. 376, nr 19, s. 1813-1823Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
BACKGROUND The instantaneous wave-free ratio (iFR) is an index used to assess the severity of coronary-artery stenosis. The index has been tested against fractional flow reserve (FFR) in small trials, and the two measures have been found to have similar diagnostic accuracy. However, studies of clinical outcomes associated with the use of iFR are lacking. We aimed to evaluate whether iFR is noninferior to FFR with respect to the rate of subsequent major adverse cardiac events.
METHODS We conducted a multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry for enrollment. A total of 2037 participants with stable angina or an acute coronary syndrome who had an indication for physiologically guided assessment of coronary-artery stenosis were randomly assigned to undergo revascularization guided by either iFR or FFR. The primary end point was the rate of a composite of death from any cause, nonfatal myocardial infarction, or unplanned revascularization within 12 months after the procedure.
RESULTS A primary end-point event occurred in 68 of 1012 patients (6.7%) in the iFR group and in 61 of 1007 (6.1%) in the FFR group (difference in event rates, 0.7 percentage points; 95% confidence interval [CI], -1.5 to 2.8; P = 0.007 for noninferiority; hazard ratio, 1.12; 95% CI, 0.79 to 1.58; P = 0.53); the upper limit of the 95% confidence interval for the difference in event rates fell within the prespecified noninferiority margin of 3.2 percentage points. The results were similar among major subgroups. The rates of myocardial infarction, target-lesion revascularization, restenosis, and stent thrombosis did not differ significantly between the two groups. A significantly higher proportion of patients in the FFR group than in the iFR group reported chest discomfort during the procedure.
CONCLUSIONS Among patients with stable angina or an acute coronary syndrome, an iFR-guided revascularization strategy was noninferior to an FFR-guided revascularization strategy with respect to the rate of major adverse cardiac events at 12 months.
Ort, förlag, år, upplaga, sidor
Massachusetts Medical Society , 2017. Vol. 376, nr 19, s. 1813-1823
Nationell ämneskategori
Kardiologi
Identifikatorer
URN: urn:nbn:se:uu:diva-323023DOI: 10.1056/NEJMoa1616540ISI: 000400891100007PubMedID: 28317438OAI: oai:DiVA.org:uu-323023DiVA, id: diva2:1104947
Anmärkning
Christoph Varenhorst, Collaborator Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI.
2017-06-022017-06-022023-11-28Bibliografiskt granskad